Download presentation
Presentation is loading. Please wait.
Published byAllyson Morris Modified over 9 years ago
1
Application of New DNA Sequencing Technologies for the Study of Epigenetic Abnormalities in Breast Cancer John R. Edwards jre13@columbia.edu Columbia Genome Center July 25th, 2007
2
Sequencing by Synthesis A new paradigm in genomic sequencing
3
DNA Polymerase Reaction
4
DNA Polymerase Reaction Modifications
5
G - Linker - O-Block-3’ Sequencing by Synthesis ACGCTAGCGATCATGCAGCTGCATCGACGCTAGCGATCATGCAGCTGCATCG TGCGATCGTGCGATCG Template Primer C A T
6
Structure of the Polymerase-DNA-Nucleotide Complex Pelletier et al. (1994) Science 264, 1891 -1903
7
Ju J, Li Z, Edwards JR, Itagaki Y. U.S. Patent (2003) 6,664,079 DNA Sequencing by Synthesis (SBS) on a Chip
8
J. Ju et al. PNAS, 2006, 103:19635-40. Molecular Structures of 3’-O-Allyl-dNTP- Allyl-Dye Nucleotide Analogues
11
Emulsion PCR Based DNA Template Preparation
12
Methylation Landscape of the Human Genome
13
CpG Methylation and Transcription Jones and Takai (2001) Science 293:1068-70
14
CpG Composition of the Human Genome
15
Fractionation of the Genome
16
McrBC and RE Digests
17
Fractionation and Analysis Pipeline
18
Fractionation Methods Show an Unbiased Coverage of the Genome McrBC = 3073 sequences RE = 2565 sequences
19
http://epigenomics.cu-genome.org/html/meth_landscape/
20
Custom Methylation Tracks on the UCSC Genome Browser
21
Methylation Status of Promoters
22
Alu Elements are Highly Methylated
23
Categorical Breakdown of Methylated and Unmethylated Compartments
24
Methylation Limits the Effective Size of the Genome Small Genome Large Genome
25
Whole-genome Profiling of Breast Cancer
26
DNA Methylation in Cancer M. Esteller (2005) Annual Review of Pharmacology and Toxicology 45:629-656. Genomic Hypomethylation Genomic instability? Activation of proto-oncogenes? Loss of Imprinting?
27
New Tools to Probe DNA Methylation in Breast Cancer Technology Requirements Whole genome approach Must examine state of repetitive elements Unbiased Must be useable for primary tumors Goals Characterize complete methylation profile of breast cancer Compare normal/tumor, tumor/tumor, tumor/cell-line Investigate potential as biomarker Understand patterns of global hypomethylation and regional hypermethylation
28
Whole-Genome Methylation Profiling
29
Acknowledgements Acknowledgements Jingyue Ju Timothy Bestor (Genetics and Development) Nicholas Turro (Chemistry) Victoria Haghighi (Psychiatry) Ju Lab James J. Russo Zengmin Li Lanrong BiXiaoxu Li Shundi ShiDae H. Kim Qingleng MengXiaopeng Bai Bestor Lab Rob Rollins Anne O’Donnell National Human Genome Research Institute/NIH NSF, Packard Foundation
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.